WebExplore Neorphys's customers. Neurotide. Neurotide is developing pain killers based on the body's own natural pain killer, endomorphin. WebExplore {Neorphys's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Neorphys CEO, …
Neorphys Evaluate
WebNeorphys Competitors & Alternatives15 Competitors. Neorphys has 15 competitors. Neorphys's competitors are Zyla Life Sciences, Annovis Bio, Afferent Pharmaceuticals, … WebWe are open Monday to Sunday from 9:00 am until 5:30 pm. An answer phone is available out of hours and any urgent requests will be dealt with normally within one hour. father of indian phytopathology
CLL Pharma VentureRadar
WebNeorphys SAS is headquartered in France . Neorphys SAS was founded in 2005. Neorphys SAS has a total of 26 patents . Related Topics. Botanical drug Herb … WebNeorphys Christel Gros Roger Lahana Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 2007-04-04 Filing date 2008-04-03 Publication date 2009-02-19 2007-04-04 Priority to FR0754279 priority Critical WebNeorphys: 01-Jan-2024: Bankruptcy: Liquidation: 00000 000000000000: 13-Feb-2015: 000: 00.00: To view Seillans Investissement’s complete exits history, request access » Seillans Investissement Investments by Industry, Year, and Region. Investments by Industry. Investments by Year. frey clean t